Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

Finasteride reduces certain hormone levels to treat prostate issues.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Progesterone helps adult male mice grow more neurons and improves memory.

Angiopoietin-1 helps hair follicle cells survive and grow, potentially treating hair loss.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Urokinase, a type of protein, helps skin cells multiply faster, especially in newborn mice.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

Finasteride may reduce prostate tumor cell invasion and spread.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Finasteride for hair loss increases risk of sexual dysfunction in young men.

Apremilast may help treat hair loss in alopecia areata.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Blocking Prostaglandin D₂ may help treat hair loss.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Low-intensity shock wave therapy is effective in treating erectile dysfunction in diabetic patients.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

New biological pathways and potential treatment targets for male pattern baldness were identified.